Volume 11,Issue 1
"Evaluation-Intervention-Follow-Up" Integrated Management: Improving Long-Term Prognosis of Neonatal Hypoxic-Ischemic Encephalopathy
In recent years, with the continuous improvement of perinatal medicine and neonatal intensive care technology, the survival rate of high-risk infants has significantly increased. Despite this, neonatal hypoxic-ischemic encephalopathy (HIE) caused by perinatal asphyxia, which leaves behind neurological sequelae, is still frequently seen. Even if these infants receive hypothermia treatment after birth, they still have certain neurodevelopmental disorders, which affect their quality of life. The treatment of HIE should not only focus on the neonatal period but also pay attention to the risk of neurological sequelae during their growth process. Implementing precise assessment, early intervention, and rehabilitation training in the later neonatal period for the pathogenesis of HIE is of great significance in reducing the occurrence of sequelae and improving the prognosis of HIE infants. This article will systematically discuss the application of the "assessment-intervention-follow-up" integrated management plan in improving the long-term prognosis of neonatal hypoxic-ischemic encephalopathy.
[1] Chan NH, Hawkins CC, Rodrigues BV, et al., 2025, Neuroprotection for neonatal hypoxic-ischemic encephalopathy: A review of novel therapies evaluated in clinical studies. Dev Med Child Neurol, 67(5): 591-599.
[2] Eunson P, 2015, The long-term health, social, and financial burden of hypoxic-ischaemic encephalopathy. Dev Med Child Neurol, 57(S3): 48-50.
[3] Anonymous, 2025, Hypoxic-ischemic encephalopathy therapeutics: a four-decade bibliometric exploration of emerging therapeutic dimensions (1985-2024). Front Pediatr, 13: 1611345.
[4] Anonymous, 2025, Hypoxic-ischemic encephalopathy therapeutics: a four-decade bibliometric exploration of emerging therapeutic dimensions (1985-2024). Front Pediatr, 13: 1611345.
[5] Sun YJ, Ma S, Fan B, et al., 2019, Therapeutic hypothermia protects photoreceptors through activating Cirbp pathway. Neurochem Int, 126: 86–95.
[6] Zhang Y, Lei Y, Jiang H, et al., 2022, Analysis of the correlation between the severity of neonatal hypoxic ischemic encephalopathy and multiple organ dysfunction. Am J Transl Res, 14(1): 311–319.
[7] Gundersen JK, Chakkarapani E, Menassa DA, et al., 2024, The effects of anaesthesia on cell death in a porcine model of neonatal hypoxic-ischaemic brain injury. BJA Open, 10: 100283.
[8] Gundersen JK, Chakkarapani E, Menassa DA, et al., 2024, The effects of anaesthesia on cell death in a porcine model of neonatal hypoxic-ischaemic brain injury. BJA Open, 10: 100283.
[9] Zhou KQ, Dhillon SK, Bennet L, et al., 2022, Targeting persistent neuroinflammation after hypoxic-ischemic encephalopathy-is exendin-4 the answer?. Int J Mol Sci, 23(17): 10191.
[10] Lin CG, Yu JL, 2009, Misconceptions in the Treatment of neonatal Hypoxic-ischemic encephalopathy and Programmed Intervention strategies. Medicine and Philosophy, 30(8): 40-41,78.
[11] Parmentier CEJ, de Vries LS, Groenendaal F, 2022, Magnetic resonance imaging in (near-)term infant ischemic encephalopathy. Diagnostics, 12(3): 645.
[12] Anonymous, 2021, Application of Vibration Spectrum Imaging in the Evaluation of Neonatal Hypoxic-Ischemic Encephalopathy. Chinese Health Standards Management, 12(1): 24-27.
[13] Yang MJ, 2018, The application value of amplitude-integrated electroencephalogram in the diagnosis of neonatal hypoxic-ischemic brain injury. Chinese Medical Innovation, 15(13): 41-44.
[14] Fang F, Hei MY, et al., 2020, The Application of Video Electroencephalogram in the Evaluation of Neurological Development in Premature infants. Medical Sciences of the Armed Police Force, 31(1): 51, 54.
[15] Wang WH, Zhang SH, Xiao XP, 2024, Clinical Application of Video electroencephalogram in Diagnosis, Treatment and Prognosis of Neonatal Brain injury. Qingdao Medical and Health, 56(3): 173-176.
[16] Wang WH, Zhang SH, Xiao XP, 2024, Clinical Application of Video electroencephalogram in Diagnosis, Treatment and Prognosis of Neonatal Brain injury. Qingdao Medical and Health, 56(3): 173-176.
[17] Huo YL, Zheng B, Wang D, et al., 2018, The diagnostic value of color Doppler ultrasound in neonatal hypoxic-ischemic encephalopathy. Chinese Journal of Ultrasound Medicine, 34(2): 101-104.
[18] Wu XJ, Guo CQ, Lin SH, et al., 2009, Color doppler flow imaging (cdfi) in the application of newborns hypoxia ischemic encephalopathy value. Journal of Jiangxi Medical College, (6): 873-874.
[19] Tan ZT, Shi L, 2003, Research on the Application of Color Doppler Ultrasound in the Diagnosis of Neonatal Hypoxic-Ischemic Encephalopathy. Chinese Journal of Eugenics and Genetics, 11(6): 113-114.
[20] Ji HL, 2019, Clinical study on dynamic monitoring and Evaluation of brain injury in neonatal Hypoxic-ischemic encephalopathy by intracranial color Doppler ultrasound. Chinese Journal of Practical Medicine, 46(19): 57-60.
[21] Laptook AR, Shankaran S, Tyson JE, et al., 2017, Effect of therapeutic hypothermia initiated after 6 hours of age on death or disability among newborns with hypoxic-ischemic encephalopathy: a randomized clinical trial. JAMA, 318(16): 1550–1560.
[22] Liu T, 2006, Hyperbaric oxygen for neonatal hypoxic-ischemic encephalopathy: a systematic review of Chinese literature. BMJ, 333(7564): 374.
[23] Bernaudin M, Marti HH, Roussel S, et al., 1999, A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cerebr Blood Flow Metabol, 19(6): 643–651.
[24] Tamura T, Aoyama M, Ukai S, et al., 2017, Neuroprotective erythropoietin attenuates microglial activation, including morphological changes, phagocytosis, and cytokine production. Brain Res, 1662: 65–74.
[25] Xiong T, Qu Y, Mu D, et al., 2011, Erythropoietin for neonatal brain injury: opportunity and challenge. Int J Dev Neurosci, 29(6): 583–591.
[26] Min YJ, Ling EA, Li F, 2020, Immunomodulatory Mechanism and Potential Therapies for Perinatal Hypoxic-Ischemic Brain Damage. Front Pharmacol, 11: 580428.
[27] Wei W, 2019, The clinical effect of the combination of ganglioside and reduced glutathione in the treatment of neonatal hypoxic ischemic encephalopathy. Chin J Mod Drug Appl, 13(18): 37–38.
[28] Wang J, Li K, 2018, Clinical observation on reduced glutathione combined with neurotrophic drugs in treatment of neonatal hypoxic-ischemic encephalopathy. Chin J New Clin Med, 11(10): 1030–1032.
[29] Wang W, Xiao Q, Ma M, et al., 2019, Clinical efficacy of monosialoganglioside in treatment of neonatal hypoxic ischemic encephalopathy. Drug Evaluation, 16(22): 38–39.
[30] Yang T, Zhang M, 2020, Effects of ganglioside combined with naloxone on neurological function in neonates with hypoxic ischemic encephalopathy. Clin Res, 28(4): 95–96.
[31] Sheng L, Li Z, 2017, Adjuvant treatment with monosialoganglioside may improve neurological outcomes in neonatal hypoxic-ischemic encephalopathy: a meta-analysis of randomized controlled trials. PLoS One, 12(8): e0183490.
[32] Zhu XY, Ye MY, Zhang AM, et al., 2015, Influence of one-year neurologic outcome of treatment on newborns with moderate and severe hypoxic-ischemic encephalopathy by rhuEP0 combined with ganglioside (GM1). Eur Rev Med Pharmacol Sci, 19(20): 3955–3960.
[33] Zhou W, Bi Y, Wei Y, et al., 2020, Effect of cephalic sub-hypothermia therapy combined with ganglioside on neonates with hypoxic-ischemic encephalopathy. Acad J Chin PLA Med Sch, 41(1): 56–59.
[34] Meng JY, Lin L, Zhang XL, 2021, The influence of kangaroo nursing combined with music intervention on the neurological function and developmental index of neonates with hypoxic-ischemic encephalopathy. Journal of the Logistics College of the Armed Police Force: Medical Edition, 30(12): 209-210.
[35] Wu XT, Bian WN, Zheng LF, et al., 2022, The influence of early comprehensive rehabilitation combined with acupoint massage on intellectual development, growth and development, and serum brain tissue injury markers in children with hypoxic-ischemic encephalopathy. Advances in Modern Biomedical Science, 22(24): 4729-4733.
[36] Zhang Q, 2023, The Influence of Combined Massage and Rehabilitation Nursing on the Growth and Development of Neonates with Hypoxic-ischemic Encephalopathy. Primary Medicine Forum, 27(12): 82-84.
[37] Yang L, Liu SM, 2020, The influence of active risk nursing combined with environmental stimulation intervention on the rehabilitation process and neurobehavior of neonatal hypoxic-ischemic encephalopathy. Reflexology and Rehabilitation Medicine, 6(8): 191-194.
[38] Dong JP, Zhao Y, Chen LN, et al., 2009, The influence of individualized collaborative rehabilitation on the prognosis of neonatal hypoxic-ischemic encephalopathy. Journal of Yunyang Medical College, 28(1): 58-59.
[39] Yang ZY, Shao XH, 2005, Discussion on Follow-up and Intervention Methods for Neonatal Hypoxic-Ischemic Encephalopathy after the neonatal period. Chinese Journal of Maternal and Child Health, 20(15): 1929-1931.
[40] Cai CL, Hu SJ, 2009, The significance of follow-up and early intervention for neonatal hypoxic-ischemic encephalopathy. Chinese Journal of Modern Pharmaceutical Application, 3(16): 196-197.